TY  - JOUR
AU  - Seibold, Petra
AU  - Webb, Adam
AU  - Aguado-Barrera, Miguel E
AU  - Azria, David
AU  - Bourgier, Celine
AU  - Brengues, Muriel
AU  - Briers, Erik
AU  - Bultijnck, Renée
AU  - Calvo-Crespo, Patricia
AU  - Carballo, Ana
AU  - Choudhury, Ananya
AU  - Cicchetti, Alessandro
AU  - Claßen, Johannes
AU  - Delmastro, Elena
AU  - Dunning, Alison M
AU  - Elliott, Rebecca M
AU  - Farcy-Jacquet, Marie-Pierre
AU  - Gabriele, Pietro
AU  - Garibaldi, Elisabetta
AU  - Gómez-Caamaño, Antonio
AU  - Gutiérrez-Enríquez, Sara
AU  - Higginson, Daniel S
AU  - Johnson, Kerstie
AU  - Lobato-Busto, Ramón
AU  - Mollà, Meritxell
AU  - Müller, Anusha
AU  - Payne, Debbie
AU  - Peleteiro, Paula
AU  - Post, Giselle
AU  - Rancati, Tiziana
AU  - Rattay, Tim
AU  - Reyes, Victoria
AU  - Rosenstein, Barry S
AU  - De Ruysscher, Dirk
AU  - De Santis, Maria Carmen
AU  - Schäfer, Jörg
AU  - Schnabel, Thomas
AU  - Sperk, Elena
AU  - Symonds, R Paul
AU  - Stobart, Hilary
AU  - Taboada-Valladares, Begoña
AU  - Talbot, Christopher J
AU  - Valdagni, Riccardo
AU  - Vega, Ana
AU  - Veldeman, Liv
AU  - Ward, Tim
AU  - Weißenberger, Christian
AU  - West, Catharine M L
AU  - Chang-Claude, Jenny
TI  - REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
JO  - Radiotherapy and oncology
VL  - 138
SN  - 0167-8140
CY  - Amsterdam [u.a.]
PB  - Elsevier Science
M1  - DKFZ-2019-01425
SP  - 59 - 67
PY  - 2019
AB  - REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk of late toxicity following radiotherapy. The purpose of this article is to provide summary descriptive data.An international, prospective cohort study recruited cancer patients in 26 hospitals in eight countries between April 2014 and March 2017. Target recruitment was 5300 patients. Eligible patients had breast, prostate or lung cancer and planned potentially curable radiotherapy. Radiotherapy was prescribed according to local regimens, but centres used standardised data collection forms. Pre-treatment blood samples were collected. Patients were followed for a minimum of 12 (lung) or 24 (breast/prostate) months and summary descriptive statistics were generated.The study recruited 2069 breast (99
LB  - PUB:(DE-HGF)16
C6  - pmid:31146072
DO  - DOI:10.1016/j.radonc.2019.04.034
UR  - https://inrepo02.dkfz.de/record/143863
ER  -